Fine epitope mapping of humanized anti-IgE monoclonal antibody omalizumab

Biochemical and Biophysical Research Communications
Lei ZhengYajun Guo

Abstract

Omalizumab is a humanized anti-IgE antibody that inhibits IgE binding to its receptors on mast cells and basophils, thus blocking the IgE-mediated release of pharmacologic mediators from these cells. Previous studies have indicated that omalizumab binds to the Cepsilon3 domain of IgE, which is the binding site of IgE receptors, but the precise epitope recognized by omalizumab is unknown. In this study, we employed the phage display peptide library technology to select peptides binding to omalizumab. A striking peptide sequence motif was recovered, which is homologous to the sequence (424)HLP(426) within the Cepsilon3 domain of IgE-Fc. Our results further indicated that omalizumab specifically bound to the synthesized peptide "(421)THPHLPRALMRS(432)" containing the (424)HLP(426) motif in IgE-Fc. We therefore conclude that the (424)HLP(426) motif is the omalizumab epitope. This epitope overlaps with the high-affinity IgE receptor-binding site, thus providing insights into the structural basis for the mechanism of action of omalizumab.

References

Jan 1, 1986·Annual Review of Immunology·H MetzgerR Quarto
Jan 1, 1993·Springer Seminars in Immunopathology·F M DavisJ Bews
Feb 5, 2000·Nature Biotechnology·T W Chang
Sep 27, 2006·Pharmacology & Therapeutics·Charles E Owen
Feb 28, 2008·Nature Reviews. Immunology·Hannah J Gould, Brian J Sutton

❮ Previous
Next ❯

Citations

Sep 6, 2012·The Journal of Biological Chemistry·Beth A WurzburgTheodore S Jardetzky
Jan 26, 2016·Vaccines·Bassel AkacheMichael J McCluskie
Oct 29, 2015·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Eva Serrano-CandelasMarta Ferrer
Apr 17, 2010·Biochemical and Biophysical Research Communications·Weizhu QianYajun Guo
May 7, 2011·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·E Jensen-Jarolim, J Singer
Mar 20, 2014·The Journal of Allergy and Clinical Immunology·Alexander EggelTheodore S Jardetzky
Aug 13, 2014·The Journal of Allergy and Clinical Immunology·Yih-Chih ChanHannah J Gould
Jun 27, 2015·Scientific Reports·Jon D WrightCarmay Lim
Apr 8, 2015·Acta Crystallographica. Section F, Structural Biology Communications·Rasmus K JensenGregers Rom Andersen
Apr 26, 2017·The Journal of Biological Chemistry·Anna M DaviesBrian J Sutton
Mar 7, 2020·Acta Crystallographica. Section F, Structural Biology Communications·Alkistis N MitropoulouAnna M Davies
Apr 25, 2020·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Alexandra LangloisPhilippe Bégin
Jan 18, 2017·Journal of Immunology Research·Arnau Navinés-FerrerMargarita Martín
Nov 8, 2017·Allergologia et immunopathologia·M Ferrer, R Madamba
Sep 28, 2020·The Journal of Allergy and Clinical Immunology·Pauline AzzanoPhilippe Bégin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basophils

Basophils are myeloid cells with a high affinity IgE receptor and is involved in inflammatory responses during allergy. Discover the latest research on Basophils here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.